These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1943333)

  • 21. [Substance abuse testing at the workplace. When is it justified?].
    Nilstun T; Westerholm P
    Lakartidningen; 1997 Apr; 94(18):1678, 1683-4. PubMed ID: 9182169
    [No Abstract]   [Full Text] [Related]  

  • 22. [A significant difference between genetic testing and substance abuse testing at workplaces].
    Jacobsson L
    Lakartidningen; 1996 May; 93(19):1820. PubMed ID: 8667811
    [No Abstract]   [Full Text] [Related]  

  • 23. Measurement properties of quantitative urine benzoylecgonine in clinical trials research.
    Delucchi KL; Jones RT; Batki SL
    Addiction; 1997 Mar; 92(3):297-302. PubMed ID: 9219391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cut-off and toxicity levels for drugs-of-abuse testing.
    MLO Med Lab Obs; 2000 Aug; 32(8 Suppl):40-1. PubMed ID: 11183960
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative assessment of blood and urine analyses in patients with acute poisonings by medical, narcotic substances and alcohol in clinical toxicology.
    Ostapenko YN; Lisovik ZA; Belova MV; Luzhnikov EA; Livanov AS
    Przegl Lek; 2005; 62(6):591-4. PubMed ID: 16225131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug abuse testing at work. Not a difficult medical-ethical problem].
    Jacobsson L
    Lakartidningen; 1995 Dec; 92(50):4778-9. PubMed ID: 8538286
    [No Abstract]   [Full Text] [Related]  

  • 27. Pressure-assisted capillary electrochromatography with electrospray ionization-mass spectrometry based on silica-based monolithic column for rapid analysis of narcotics.
    Lu M; Zhang L; Feng Q; Xia S; Chi Y; Tong P; Chen G
    Electrophoresis; 2008 Feb; 29(4):936-43. PubMed ID: 18213603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis.
    Jones RT
    NIDA Res Monogr; 1997; 175():221-34. PubMed ID: 9467801
    [No Abstract]   [Full Text] [Related]  

  • 29. [Let the methadone patients in Stockholm tell--with the possibility to change their program].
    Gunne L
    Lakartidningen; 2001 Jul; 98(30-31):3359. PubMed ID: 11521347
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and professional reference guides. Cut-off and toxicity levels for drugs-of-abuse testing.
    Williams RA
    MLO Med Lab Obs; 2001 Aug; 33(8 Suppl):16-7. PubMed ID: 11571830
    [No Abstract]   [Full Text] [Related]  

  • 33. Workshop on the detection and control of abuse of narcotics, barbiturates, and amphetamines; San Juan, Puerto Rico, December 13-15, 1965.
    Leonard F
    Psychopharmacol Bull; 1966 Dec; 3(4):21-6. PubMed ID: 5981117
    [No Abstract]   [Full Text] [Related]  

  • 34. [Death attributed to toxic interaction of tramadol and other drugs].
    Galer K; Krzyzanowski M
    Arch Med Sadowej Kryminol; 2004; 54(1):73-8. PubMed ID: 15129488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medical tests in occupational environment are not uncontroversial. Consider the alternatives, and let the committee decide!].
    Westerholm B
    Lakartidningen; 1996 Feb; 93(6):444-5. PubMed ID: 8637313
    [No Abstract]   [Full Text] [Related]  

  • 36. Doping: world agency sets standards to promote fair play.
    Ljungqvist A; Horta L; Wadler G
    Nature; 2008 Oct; 455(7217):1176. PubMed ID: 18971999
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of opiates in urine: a cost-effective low risk immunoassay procedure.
    Moore FM; Simpson D
    Med Lab Sci; 1989 Oct; 46(4):309-12. PubMed ID: 2515406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Snack crackers yield opiate-positive urine.
    McCutcheon JR; Wood PG
    Clin Chem; 1995 May; 41(5):769-70. PubMed ID: 7729065
    [No Abstract]   [Full Text] [Related]  

  • 39. HAIRVEQ: an external quality control scheme for drugs of abuse analysis in hair.
    Pichini S; Ventura M; Pujadas M; Ventura R; Pellegrini M; Zuccaro P; Pacifici R; de la Torre R
    Forensic Sci Int; 2004 Oct; 145(2-3):109-15. PubMed ID: 15451081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
    Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
    J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.